SYRC_HUMAN - dbPTM
SYRC_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SYRC_HUMAN
UniProt AC P54136
Protein Name Arginine--tRNA ligase, cytoplasmic
Gene Name RARS
Organism Homo sapiens (Human).
Sequence Length 660
Subcellular Localization Cytoplasm . Cytoplasm, cytosol .
Protein Description Forms part of a macromolecular complex that catalyzes the attachment of specific amino acids to cognate tRNAs during protein synthesis. [PubMed: 25288775 Modulates the secretion of AIMP1 and may be involved in generation of the inflammatory cytokine EMAP2 from AIMP1]
Protein Sequence MDVLVSECSARLLQQEEEIKSLTAEIDRLKNCGCLGASPNLEQLQEENLKLKYRLNILRKSLQAERNKPTKNMINIISRLQEVFGHAIKAAYPDLENPPLLVTPSQQAKFGDYQCNSAMGISQMLKTKEQKVNPREIAENITKHLPDNECIEKVEIAGPGFINVHLRKDFVSEQLTSLLVNGVQLPALGENKKVIVDFSSPNIAKEMHVGHLRSTIIGESISRLFEFAGYDVLRLNHVGDWGTQFGMLIAHLQDKFPDYLTVSPPIGDLQVFYKESKKRFDTEEEFKKRAYQCVVLLQGKNPDITKAWKLICDVSRQELNKIYDALDVSLIERGESFYQDRMNDIVKEFEDRGFVQVDDGRKIVFVPGCSIPLTIVKSDGGYTYDTSDLAAIKQRLFEEKADMIIYVVDNGQSVHFQTIFAAAQMIGWYDPKVTRVFHAGFGVVLGEDKKKFKTRSGETVRLMDLLGEGLKRSMDKLKEKERDKVLTAEELNAAQTSVAYGCIKYADLSHNRLNDYIFSFDKMLDDRGNTAAYLLYAFTRIRSIARLANIDEEMLQKAARETKILLDHEKEWKLGRCILRFPEILQKILDDLFLHTLCDYIYELATAFTEFYDSCYCVEKDRQTGKILKVNMWRMLLCEAVAAVMAKGFDILGIKPVQRM
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MDVLVSEC
-------CCHHHHHH
7.8922223895
6Phosphorylation--MDVLVSECSARLL
--CCHHHHHHHHHHH
28.8220860994
20UbiquitinationLQQEEEIKSLTAEID
HHCHHHHHHHHHHHH
42.5721890473
202-HydroxyisobutyrylationLQQEEEIKSLTAEID
HHCHHHHHHHHHHHH
42.57-
20UbiquitinationLQQEEEIKSLTAEID
HHCHHHHHHHHHHHH
42.5722053931
20 (in isoform 1)Ubiquitination-42.5721890473
20UbiquitinationLQQEEEIKSLTAEID
HHCHHHHHHHHHHHH
42.5721890473
21PhosphorylationQQEEEIKSLTAEIDR
HCHHHHHHHHHHHHH
36.2925159151
302-HydroxyisobutyrylationTAEIDRLKNCGCLGA
HHHHHHHHCCCCCCC
51.60-
30AcetylationTAEIDRLKNCGCLGA
HHHHHHHHCCCCCCC
51.6026051181
30UbiquitinationTAEIDRLKNCGCLGA
HHHHHHHHCCCCCCC
51.6032015554
38PhosphorylationNCGCLGASPNLEQLQ
CCCCCCCCCCHHHHH
16.7225159151
50AcetylationQLQEENLKLKYRLNI
HHHHHCHHHHHHHHH
55.2925953088
50UbiquitinationQLQEENLKLKYRLNI
HHHHHCHHHHHHHHH
55.2932015554
60AcetylationYRLNILRKSLQAERN
HHHHHHHHHHHHHHC
52.6619608861
61PhosphorylationRLNILRKSLQAERNK
HHHHHHHHHHHHHCC
21.1926699800
71UbiquitinationAERNKPTKNMINIIS
HHHCCCCHHHHHHHH
53.7124816145
73SulfoxidationRNKPTKNMINIISRL
HCCCCHHHHHHHHHH
2.3728183972
103PhosphorylationENPPLLVTPSQQAKF
CCCCEEECHHHHCCC
19.7225850435
105PhosphorylationPPLLVTPSQQAKFGD
CCEEECHHHHCCCCC
26.0925850435
115GlutathionylationAKFGDYQCNSAMGIS
CCCCCCCCHHHHHHH
3.3722555962
126UbiquitinationMGISQMLKTKEQKVN
HHHHHHHHCCCCCCC
52.8132015554
133 (in isoform 2)Ubiquitination-36.6321890473
143TrimethylationEIAENITKHLPDNEC
HHHHHHHHHCCCCHH
39.07-
143AcetylationEIAENITKHLPDNEC
HHHHHHHHHCCCCHH
39.0725953088
143MethylationEIAENITKHLPDNEC
HHHHHHHHHCCCCHH
39.07-
143UbiquitinationEIAENITKHLPDNEC
HHHHHHHHHCCCCHH
39.0729967540
150GlutathionylationKHLPDNECIEKVEIA
HHCCCCHHEEEEEEC
6.4522555962
153AcetylationPDNECIEKVEIAGPG
CCCHHEEEEEECCCC
25.8426051181
193UbiquitinationPALGENKKVIVDFSS
CCCCCCCEEEEECCC
49.1029967540
199PhosphorylationKKVIVDFSSPNIAKE
CEEEEECCCCCHHHH
40.1825627689
200PhosphorylationKVIVDFSSPNIAKEM
EEEEECCCCCHHHHC
23.2025159151
202 (in isoform 2)Ubiquitination-49.1221890473
205UbiquitinationFSSPNIAKEMHVGHL
CCCCCHHHHCCHHHH
52.3421890473
205AcetylationFSSPNIAKEMHVGHL
CCCCCHHHHCCHHHH
52.3423954790
205MalonylationFSSPNIAKEMHVGHL
CCCCCHHHHCCHHHH
52.3426320211
205UbiquitinationFSSPNIAKEMHVGHL
CCCCCHHHHCCHHHH
52.3423000965
205 (in isoform 1)Ubiquitination-52.3421890473
205UbiquitinationFSSPNIAKEMHVGHL
CCCCCHHHHCCHHHH
52.3421890473
207SulfoxidationSPNIAKEMHVGHLRS
CCCHHHHCCHHHHHH
2.8230846556
215PhosphorylationHVGHLRSTIIGESIS
CHHHHHHHHHHHHHH
15.3521712546
230PhosphorylationRLFEFAGYDVLRLNH
HHHHHCCCCEEECCC
10.23-
263PhosphorylationFPDYLTVSPPIGDLQ
CCCCEEECCCCCCCH
21.52-
274UbiquitinationGDLQVFYKESKKRFD
CCCHHHHHHHHHCCC
44.0122817900
274 (in isoform 1)Ubiquitination-44.0121890473
275 (in isoform 2)Ubiquitination-57.3121890473
277UbiquitinationQVFYKESKKRFDTEE
HHHHHHHHHCCCCHH
49.4022817900
278MalonylationVFYKESKKRFDTEEE
HHHHHHHHCCCCHHH
68.5226320211
278UbiquitinationVFYKESKKRFDTEEE
HHHHHHHHCCCCHHH
68.5222817900
279MethylationFYKESKKRFDTEEEF
HHHHHHHCCCCHHHH
38.11115490337
282PhosphorylationESKKRFDTEEEFKKR
HHHHCCCCHHHHHHH
42.4520068231
2872-HydroxyisobutyrylationFDTEEEFKKRAYQCV
CCCHHHHHHHHHHHE
44.63-
287AcetylationFDTEEEFKKRAYQCV
CCCHHHHHHHHHHHE
44.6323954790
287UbiquitinationFDTEEEFKKRAYQCV
CCCHHHHHHHHHHHE
44.6324816145
288AcetylationDTEEEFKKRAYQCVV
CCHHHHHHHHHHHEE
47.8125953088
290 (in isoform 2)Ubiquitination-13.9721890473
291PhosphorylationEEFKKRAYQCVVLLQ
HHHHHHHHHHEEEEC
13.3828152594
293GlutathionylationFKKRAYQCVVLLQGK
HHHHHHHHEEEECCC
1.1722555962
3002-HydroxyisobutyrylationCVVLLQGKNPDITKA
HEEEECCCCCCHHHH
52.96-
300AcetylationCVVLLQGKNPDITKA
HEEEECCCCCCHHHH
52.9626051181
300UbiquitinationCVVLLQGKNPDITKA
HEEEECCCCCCHHHH
52.96-
306AcetylationGKNPDITKAWKLICD
CCCCCHHHHHHHHHH
53.2126051181
306UbiquitinationGKNPDITKAWKLICD
CCCCCHHHHHHHHHH
53.2129967540
309AcetylationPDITKAWKLICDVSR
CCHHHHHHHHHHHCH
32.6025953088
321UbiquitinationVSRQELNKIYDALDV
HCHHHHHHHHHHHCH
56.0929967540
321 (in isoform 2)Ubiquitination-56.0921890473
329PhosphorylationIYDALDVSLIERGES
HHHHHCHHHHHCCCC
24.2426270265
338PhosphorylationIERGESFYQDRMNDI
HHCCCCHHHHHHHHH
20.84-
341MethylationGESFYQDRMNDIVKE
CCCHHHHHHHHHHHH
15.41115490329
342SulfoxidationESFYQDRMNDIVKEF
CCHHHHHHHHHHHHH
7.7021406390
3472-HydroxyisobutyrylationDRMNDIVKEFEDRGF
HHHHHHHHHHHHCCC
57.95-
347AcetylationDRMNDIVKEFEDRGF
HHHHHHHHHHHHCCC
57.9526051181
347UbiquitinationDRMNDIVKEFEDRGF
HHHHHHHHHHHHCCC
57.9521906983
347 (in isoform 1)Ubiquitination-57.9521890473
352MethylationIVKEFEDRGFVQVDD
HHHHHHHCCCEEECC
33.00115490321
362UbiquitinationVQVDDGRKIVFVPGC
EEECCCCEEEEECCC
49.0721890473
362NeddylationVQVDDGRKIVFVPGC
EEECCCCEEEEECCC
49.0732015554
362UbiquitinationVQVDDGRKIVFVPGC
EEECCCCEEEEECCC
49.0723000965
362 (in isoform 1)Ubiquitination-49.0721890473
362UbiquitinationVQVDDGRKIVFVPGC
EEECCCCEEEEECCC
49.0721890473
369S-nitrosocysteineKIVFVPGCSIPLTIV
EEEEECCCCCEEEEE
2.46-
369GlutathionylationKIVFVPGCSIPLTIV
EEEEECCCCCEEEEE
2.4622555962
369S-nitrosylationKIVFVPGCSIPLTIV
EEEEECCCCCEEEEE
2.4619483679
369S-palmitoylationKIVFVPGCSIPLTIV
EEEEECCCCCEEEEE
2.4629575903
370PhosphorylationIVFVPGCSIPLTIVK
EEEECCCCCEEEEEE
32.9128348404
374PhosphorylationPGCSIPLTIVKSDGG
CCCCCEEEEEECCCC
20.5428102081
377AcetylationSIPLTIVKSDGGYTY
CCEEEEEECCCCCEE
38.6923236377
377MalonylationSIPLTIVKSDGGYTY
CCEEEEEECCCCCEE
38.6926320211
377UbiquitinationSIPLTIVKSDGGYTY
CCEEEEEECCCCCEE
38.6933845483
378PhosphorylationIPLTIVKSDGGYTYD
CEEEEEECCCCCEEE
30.5028152594
382PhosphorylationIVKSDGGYTYDTSDL
EEECCCCCEEEHHHH
13.9928152594
383PhosphorylationVKSDGGYTYDTSDLA
EECCCCCEEEHHHHH
20.4228152594
384PhosphorylationKSDGGYTYDTSDLAA
ECCCCCEEEHHHHHH
14.5628152594
386PhosphorylationDGGYTYDTSDLAAIK
CCCCEEEHHHHHHHH
17.4628152594
387PhosphorylationGGYTYDTSDLAAIKQ
CCCEEEHHHHHHHHH
27.9428152594
393UbiquitinationTSDLAAIKQRLFEEK
HHHHHHHHHHHHHHC
25.3321890473
3932-HydroxyisobutyrylationTSDLAAIKQRLFEEK
HHHHHHHHHHHHHHC
25.33-
393AcetylationTSDLAAIKQRLFEEK
HHHHHHHHHHHHHHC
25.3327452117
393UbiquitinationTSDLAAIKQRLFEEK
HHHHHHHHHHHHHHC
25.3323000965
393 (in isoform 1)Ubiquitination-25.3321890473
393UbiquitinationTSDLAAIKQRLFEEK
HHHHHHHHHHHHHHC
25.3321890473
399 (in isoform 2)Ubiquitination-46.3321890473
449UbiquitinationGVVLGEDKKKFKTRS
CEEECCCHHHCCCCC
54.2733845483
450 (in isoform 2)Ubiquitination-75.6321890473
451AcetylationVLGEDKKKFKTRSGE
EECCCHHHCCCCCCC
58.817681275
453AcetylationGEDKKKFKTRSGETV
CCCHHHCCCCCCCCH
52.497681285
459PhosphorylationFKTRSGETVRLMDLL
CCCCCCCCHHHHHHH
17.91-
463SulfoxidationSGETVRLMDLLGEGL
CCCCHHHHHHHHHHH
2.0921406390
4712-HydroxyisobutyrylationDLLGEGLKRSMDKLK
HHHHHHHHHHHHHHH
53.97-
471UbiquitinationDLLGEGLKRSMDKLK
HHHHHHHHHHHHHHH
53.9721906983
471 (in isoform 1)Ubiquitination-53.9721890473
472DimethylationLLGEGLKRSMDKLKE
HHHHHHHHHHHHHHH
42.11-
472MethylationLLGEGLKRSMDKLKE
HHHHHHHHHHHHHHH
42.1118938727
476UbiquitinationGLKRSMDKLKEKERD
HHHHHHHHHHHHHHH
53.4722817900
480UbiquitinationSMDKLKEKERDKVLT
HHHHHHHHHHHHCCC
57.3624816145
4842-HydroxyisobutyrylationLKEKERDKVLTAEEL
HHHHHHHHCCCHHHH
45.42-
485 (in isoform 2)Ubiquitination-7.2321890473
496PhosphorylationEELNAAQTSVAYGCI
HHHHHHHHHHHHCCH
22.0528152594
497PhosphorylationELNAAQTSVAYGCIK
HHHHHHHHHHHCCHH
7.8328152594
500PhosphorylationAAQTSVAYGCIKYAD
HHHHHHHHCCHHHHH
15.4628152594
502GlutathionylationQTSVAYGCIKYADLS
HHHHHHCCHHHHHCC
1.2622555962
504AcetylationSVAYGCIKYADLSHN
HHHHCCHHHHHCCCC
38.1626051181
504UbiquitinationSVAYGCIKYADLSHN
HHHHCCHHHHHCCCC
38.1621963094
505PhosphorylationVAYGCIKYADLSHNR
HHHCCHHHHHCCCCC
5.8528152594
516PhosphorylationSHNRLNDYIFSFDKM
CCCCCHHEEEEHHHH
11.6428152594
519PhosphorylationRLNDYIFSFDKMLDD
CCHHEEEEHHHHHCC
23.9921712546
522AcetylationDYIFSFDKMLDDRGN
HEEEEHHHHHCCCCC
39.0826822725
522UbiquitinationDYIFSFDKMLDDRGN
HEEEEHHHHHCCCCC
39.0821906983
522 (in isoform 1)Ubiquitination-39.0821890473
536PhosphorylationNTAAYLLYAFTRIRS
CHHHHHHHHHHHHHH
9.3222817900
554SulfoxidationLANIDEEMLQKAARE
HCCCCHHHHHHHHHH
4.5221406390
5572-HydroxyisobutyrylationIDEEMLQKAARETKI
CCHHHHHHHHHHHCC
39.80-
557AcetylationIDEEMLQKAARETKI
CCHHHHHHHHHHHCC
39.8027452117
557UbiquitinationIDEEMLQKAARETKI
CCHHHHHHHHHHHCC
39.8021963094
557 (in isoform 1)Ubiquitination-39.8021890473
5632-HydroxyisobutyrylationQKAARETKILLDHEK
HHHHHHHCCCCCCHH
26.97-
563UbiquitinationQKAARETKILLDHEK
HHHHHHHCCCCCCHH
26.9733845483
570AcetylationKILLDHEKEWKLGRC
CCCCCCHHHHHHHHH
66.5123236377
570UbiquitinationKILLDHEKEWKLGRC
CCCCCCHHHHHHHHH
66.5129967540
573AcetylationLDHEKEWKLGRCILR
CCCHHHHHHHHHHHH
42.0026051181
573UbiquitinationLDHEKEWKLGRCILR
CCCHHHHHHHHHHHH
42.0027667366
583 (in isoform 2)Ubiquitination-54.3321890473
629AcetylationRQTGKILKVNMWRML
CCCCCEEEHHHHHHH
34.7325953088
638GlutathionylationNMWRMLLCEAVAAVM
HHHHHHHHHHHHHHH
2.5122555962
655UbiquitinationGFDILGIKPVQRM--
CCCCCCCCCCCCC--
37.0223000965
655 (in isoform 1)Ubiquitination-37.0221890473

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of SYRC_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SYRC_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SYRC_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SYQ_HUMANQARSphysical
10801842
AIMP1_HUMANAIMP1physical
22863883
AIMP2_HUMANAIMP2physical
22863883
ASNA_HUMANASNA1physical
22863883
DNJA1_HUMANDNAJA1physical
22863883
IF2G_HUMANEIF2S3physical
22863883
IF6_HUMANEIF6physical
22863883
HXK1_HUMANHK1physical
22863883
CCAR2_HUMANCCAR2physical
22863883
SYQ_HUMANQARSphysical
22863883
RLA0_HUMANRPLP0physical
22863883
TBB3_HUMANTUBB3physical
22863883
TBB5_HUMANTUBBphysical
22863883
AIMP1_HUMANAIMP1physical
26344197
SYDC_HUMANDARSphysical
26344197
MCA3_HUMANEEF1E1physical
26344197
SYEP_HUMANEPRSphysical
26344197
SYIC_HUMANIARSphysical
26344197
SYK_HUMANKARSphysical
26344197
SYLC_HUMANLARSphysical
26344197
SYMC_HUMANMARSphysical
26344197
SYQ_HUMANQARSphysical
26344197
AIMP1_HUMANAIMP1physical
28514442
SYLC_HUMANLARSphysical
28514442
SYDC_HUMANDARSphysical
28514442
SYTC2_HUMANTARSL2physical
28514442
MCA3_HUMANEEF1E1physical
28514442
SYIC_HUMANIARSphysical
28514442
NECT2_HUMANPVRL2physical
28514442
SYEP_HUMANEPRSphysical
28514442
SYMC_HUMANMARSphysical
28514442
AIMP2_HUMANAIMP2physical
28514442
NCPR_HUMANPORphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
616140Leukodystrophy, hypomyelinating, 9 (HLD9)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SYRC_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-38, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-60 AND LYS-205, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-38, AND MASS SPECTROMETRY.

TOP